These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 13719008)

  • 1. [The level of serum properdin in gestosis within the framework of natural aspecific immunity].
    CUTRERA A
    Minerva Ginecol; 1961 Jun; 13():577-8. PubMed ID: 13719008
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of serum leptin level as a marker of severity of pre eclampsia.
    Mumtaz F; Memon AR; Yousfani S; Tahir SM; Khushk I; Memon M; Memon A
    J Ayub Med Coll Abbottabad; 2008; 20(1):13-5. PubMed ID: 19024177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Fibrinolysis and factors of aspecific immunity. Preliminary note].
    Ferrauto A; Giuffrida G; Terranova R
    Boll Soc Ital Biol Sper; 1965 Dec; 41(24):1488-91. PubMed ID: 5878160
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum visfatin levels in late pregnancy and pre-eclampsia.
    Hu W; Wang Z; Wang H; Huang H; Dong M
    Acta Obstet Gynecol Scand; 2008; 87(4):413-8. PubMed ID: 18382866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations of serum resistin in normal pregnancy and pre-eclampsia.
    Chen D; Dong M; Fang Q; He J; Wang Z; Yang X
    Clin Sci (Lond); 2005 Jan; 108(1):81-4. PubMed ID: 15377276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal serum interleukin-10, interleukin-2 and interleukin-6 in pre-eclampsia and eclampsia.
    Borekci B; Aksoy H; Al RA; Demircan B; Kadanali S
    Am J Reprod Immunol; 2007 Jul; 58(1):56-64. PubMed ID: 17565548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Properdin and natural resistance].
    EYQUEM A
    Rev Fr Etud Clin Biol; 1960; 5():540-4. PubMed ID: 13697721
    [No Abstract]   [Full Text] [Related]  

  • 8. Aberrant uterine natural killer (NK)-cell expression and altered placental and serum levels of the NK-cell promoting cytokine interleukin-12 in pre-eclampsia.
    Bachmayer N; Rafik Hamad R; Liszka L; Bremme K; Sverremark-Ekström E
    Am J Reprod Immunol; 2006; 56(5-6):292-301. PubMed ID: 17076673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P-type inositol phosphoglycans in serum and amniotic fluid in active pre-eclampsia.
    Paine MA; Scioscia M; Gumaa KA; Rodeck CH; Rademacher TW
    J Reprod Immunol; 2006 Apr; 69(2):165-79. PubMed ID: 16384607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The interest of the plasma estrone + estradiol/estriol relationship in the surveillance of threatened premature birth, late pre-eclampsia and prolonged pregnancy].
    Wolff F; Frenkel H; Skoulios G; Schick AR; Leissner P; Muller P
    Rev Fr Gynecol Obstet; 1973 Feb; 68(2):93-7. PubMed ID: 17471690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [On the relation between aspecific immunity and tumors; recent observations].
    NAGY I; CSAKY G; LUST I; CSEH G
    Krebsarzt; 1961 Apr; 16():170-5. PubMed ID: 13727485
    [No Abstract]   [Full Text] [Related]  

  • 12. New humoral aspecific immunological factor: the properdin system.
    ZANGAGLIA O
    Riv Emoter Immunoematol; 1957; 4(3):215-27. PubMed ID: 13506459
    [No Abstract]   [Full Text] [Related]  

  • 13. [Antibiotics and some properties of normal serum (bactericidal property and properdin)].
    TOSHKOV A; NOEVA K
    Izv Mikrobiol Inst (Sofiia); 1962; 14():145-50. PubMed ID: 13993768
    [No Abstract]   [Full Text] [Related]  

  • 14. [Properdin: a new blood protein; its importance in phenomena of aspecific immunological defense].
    MURICCHIO C
    Ann Med Nav (Roma); 1958; 63(4):457-69. PubMed ID: 13595442
    [No Abstract]   [Full Text] [Related]  

  • 15. [Research on the natural immunity to infection by gramnegative bacteria. The properdin system as a mechanism of natural immunity. Relationship between nonspecific immune defenses and the properdin system. Note I].
    BO G
    Boll Ist Sieroter Milan; 1960; 39():151-62. PubMed ID: 13801764
    [No Abstract]   [Full Text] [Related]  

  • 16. The expression and concentration of CD40 ligand in normal pregnancy and pre-eclampsia.
    Darmochwal-Kolarz D; Kolarz B; Surdacka A; Rolinski J; Leszczynska-Gorzelak B; Oleszczuk J
    J Reprod Immunol; 2009 Jan; 79(2):215-9. PubMed ID: 19201484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of sera on the adhesion of natural killer cells to the endothelium in severe pre-eclampsia.
    Wei J; Satomi M; Negishi Y; Matsumura Y; Miura A; Nishi Y; Asakura H; Takeshita T
    J Obstet Gynaecol Res; 2006 Oct; 32(5):443-8. PubMed ID: 16984509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accuracy of serum uric acid as a predictive test for maternal complications in pre-eclampsia: bivariate meta-analysis and decision analysis.
    Koopmans CM; van Pampus MG; Groen H; Aarnoudse JG; van den Berg PP; Mol BW
    Eur J Obstet Gynecol Reprod Biol; 2009 Sep; 146(1):8-14. PubMed ID: 19540647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Properdin system in tumors. I. Properdin level in normal and in tumorbearing patients].
    HOLOUBEK V; KMETY E; ORAVEC C
    Cesk Onkol; 1956; 3(4):274-8. PubMed ID: 13396828
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum advanced oxidation protein products, myeloperoxidase and ascorbic acid in pre-eclampsia and eclampsia.
    Noyan T; Güler A; Sekeroğlu MR; Kamaci M
    Aust N Z J Obstet Gynaecol; 2006 Dec; 46(6):486-91. PubMed ID: 17116052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.